Pages that link to "Q34400733"

The following pages link to Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver (Q34400733):

Displaying 40 items.

• Expression of ABC Efflux transporters in placenta from women with insulin-managed diabetes (Q28482811) (← links)
• A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. (Q30375556) (← links)
• Folate augmentation of treatment - evaluation for depression (FolATED): protocol of a randomised controlled trial (Q33305713) (← links)
• Relationship between P-glycoprotein and second-generation antipsychotics. (Q34208133) (← links)
• Induction of P-glycoprotein in lymphocytes by carbamazepine and rifampicin: the role of nuclear hormone response elements (Q34547632) (← links)
• Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial (Q34622955) (← links)
• Plasmodium falciparum strains harboring dihydrofolate reductase with the I164L mutation are absent in Malawi and Zambia even under antifolate drug pressure (Q34657000) (← links)
• Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein) (Q34994901) (← links)
• Genetic and non-genetic determinants of raltegravir penetration into cerebrospinal fluid: a single arm pharmacokinetic study (Q35070434) (← links)
• Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury (Q35095391) (← links)
• Comparative description of haplotype structure and genetic diversity of MDR1 (ABCB1) in HIV-positive and HIV-negative populations (Q35295887) (← links)
• Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene (Q35809516) (← links)
• Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness (Q35846595) (← links)
• Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes. (Q36094919) (← links)
• Association between ABCB1 Polymorphisms and Antidepressant Treatment Response in Taiwanese Major Depressive Patients (Q36325439) (← links)
• ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research. (Q36592129) (← links)
• Pharmacogenetics of opioids (Q36752672) (← links)
• Association between polymorphisms of XRCC1, p53 and MDR1 genes, the expression of their protein products and prognostic significance in human breast cancer. (Q36771421) (← links)
• Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer (Q36972551) (← links)
• Interindividual variability of methadone response: impact of genetic polymorphism (Q37142009) (← links)
• Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues (Q37208437) (← links)
• Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation (Q37705351) (← links)
• Multidrug resistance in the chronic lymphoproliferative disorders (Q37771031) (← links)
• Molecular Mechanisms of Drug Transporter Regulation (Q37811969) (← links)
• The pharmacogenetics of antiplatelet agents: towards personalized therapy? (Q37913976) (← links)
• Association Between Human Pain-Related Genotypes and Variability in Opioid Analgesia: An Updated Review (Q38247246) (← links)
• Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature (Q38414396) (← links)
• Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs. (Q38957969) (← links)
• Multigene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19, and ABCB1. (Q39752018) (← links)
• Is Ticagrelor the Antiplatelet Therapy Panacea? (Q42671120) (← links)
• Moving about (Q42758983) (← links)
• Response to antiplatelet treatment: from genes to outcome (Q42923268) (← links)
• The effect of ABCB1 polymorphism on the pharmacokinetics of saquinavir alone and in combination with ritonavir. (Q43574587) (← links)
• Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study (Q44554143) (← links)
• ABCB1 single nucleotide polymorphisms in the Brazilian population (Q47815549) (← links)
• Pilot study examining the frequency of several gene polymorphisms involved in morphine pharmacodynamics and pharmacokinetics in a morbidly obese population (Q48364253) (← links)
• Pharmacogenotyping of CYP3A5 in predicting dose-adjusted trough levels of tacrolimus among Malaysian kidney-transplant patients. (Q54378695) (← links)
• G2677T and C3435T Genotype and Haplotype Are Associated With HepaticABCB1(MDR1) Expression (Q58869653) (← links)
• ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial (Q64051810) (← links)
• Association between 8 P-glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinaemia (Q90557061) (← links)